Literature DB >> 20131368

Analysis of hearing preservation after endolymphatic mastoid sac surgery for Meniere's disease.

Gordon H Sun1, Randal Leung, Ravi N Samy, Jacob S McAfee, Matthew J Hearst, Christopher R Savage, Daniel I Choo, Myles L Pensak.   

Abstract

OBJECTIVES/HYPOTHESIS: Comparison of audiometric outcomes between patients with definite Meniere's disease who underwent endolymphatic mastoid sac surgery (EMSS) following failed medical therapy and patients who underwent medical therapy only. STUDY
DESIGN: Retrospective chart review of 456 consecutive patients between 1997 and 2006.
METHODS: Outcome measures were changes in pure-tone average (PTA), word recognition score (WRS), and speech reception threshold (SRT).
RESULTS: Of 58 qualified patients, 29 who underwent EMSS after failing medical therapy showed a 4 dB decrease in PTA, a 2% increase in WRS, and a 2 dB decrease in SRT. Twenty-nine patients treated with medical therapy only demonstrated a 1 dB PTA increase, 2% WRS improvement, and 2 dB SRT improvement. No significant difference was noted between the medically and surgically managed patients in terms of changes in PTA (P = .34) or WRS (P = .95) after treatment. Of all patients in the study, 60% had no clinically significant change in hearing, whereas 24% improved and 16% worsened. The distribution of post-treatment hearing changes between the medical and surgical groups was statistically insignificant (P = .17).
CONCLUSIONS: The changes in PTA and WRS among patients with Meniere's disease managed with medical therapy or EMSS were not statistically significant. Although performing EMSS to treat the vertigo of Meniere's disease does not appear to be associated with an increased risk of deteriorating auditory function after treatment, surgery also does not confer an increased likelihood of stabilizing or improving hearing.

Entities:  

Mesh:

Year:  2010        PMID: 20131368     DOI: 10.1002/lary.20787

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Intratympanic dexamethasone injections for refractory Meniere' s disease.

Authors:  Hongmiao Ren; Tuanfang Yin; Yongde Lu; Weijia Kong; Jihao Ren
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Comparison of gentamicin distribution in the inner ear following administration via the endolymphatic sac or round window.

Authors:  Yiliang Zhang; Ru Zhang; Chunfu Dai; Peter S Steyger; Yongfu Yu
Journal:  Laryngoscope       Date:  2010-10       Impact factor: 3.325

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.